Mayumi Nakagawa

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 5

Top Topics

Cervical Cancer Screening

Regulatory T Cells

Candida Albicans

Top Venues

Clinical and vaccine immunology : CVI

Cancer control : journal of the Moffitt Cancer Center

Health science reports

SAGE open medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sumit K Shah, Brittany E Demmings, Milan Bimali, Kristie Hadden, Mayumi Nakagawa
Assessing the Feasibility of an Online Module for Promoting Cancer Prevention Measures. Cancer control : journal of the Moffitt Cancer Center 28 (2022)
Sumit K Shah, Maggie Jones-Carr, Milan Bimali, L Joseph Su, Mayumi Nakagawa
An Online Survey and Focus Groups for Promoting Cancer Prevention Measures. Journal of cancer education : the official journal of the American Association for Cancer Education (2021)
Rahul Ravilla, Hannah N Coleman, Cheryl-Emiliane Chow, Luisa Chan, Barbara J Fuhrman, William W Greenfield, Michael Scott Robeson, Kathryn Iverson, Horace Spencer, Mayumi Nakagawa
Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion. Integrative cancer therapies 18 (2020)
Benjamin J Lieblong, Brooke E E Montgomery, L Joseph Su, Mayumi Nakagawa
Natural history of human papillomavirus and vaccinations in men: A literature review. Health science reports 2 (5) (2019)
Al-Ola Abdallah, Hannah Coleman, Mohamed Kamel, Rodney Davis, Teri Landrum, Horace Spencer, Sam Mackintosh, Fade A Mahmoud, Natasa Milojkovic, Chester Wicker, Konstantinos Arnaoutakis, Mayumi Nakagawa
A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant. SAGE open medicine 6 (2018)
Andrea Moerman-Herzog, Mayumi Nakagawa
Early Defensive Mechanisms against Human Papillomavirus Infection. Clinical and vaccine immunology : CVI 22 (8) (2015)
Mayumi Nakagawa, William Greenfield, Andrea Moerman-Herzog, Hannah N Coleman
Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) Types in Recipients of HPV Therapeutic Vaccines. Clinical and vaccine immunology : CVI 22 (7) (2015)